Doctor with a tablet

Guidelines and codes for COVID-19 vaccine administration


Will Capital BlueCross cover COVID-19 vaccinations?

The vaccine itself will be paid for through funding authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act. Administration of the vaccine by a provider (network and non-network during the PHE) will be covered for both commercial and Medicare Advantage members.

For Calendar Years 2020 and 2021, Medicare payment for the COVID-19 vaccine and its administration for beneficiaries enrolled in Medicare Advantage plans will be made through the original fee-for-service Medicare program. Submit claims for administering the COVID-19 vaccine to the CMS Medicare Administrative Contractor (MAC) using product-specific codes for each vaccine approved.

For a provider to receive and administer the COVID-19 vaccine, the Department of Health requires that you:

  • Be credentialed/licensed in Pennsylvania
  • Sign and agree to the conditions in the CDC COVID-19 Vaccination Program Provider Agreement
  • Fully complete the CDC COVID-19 Vaccination Provider Profile form for each location where the COVID-19 vaccine will be administered

We encourage you to access the Department of Health's website for additional details.

What codes should we use to bill vaccine administration for COVID-19?

The American Medical Association posted a press release on November 10, 2020 in which it announces the addition of new CPT® codes to report immunization for the novel coronavirus (SARS-CoV-2). New CPT® codes have been assigned to each coronavirus vaccine and to administration codes, which are unique to each vaccine.

The new CPT® codes for the administration of the vaccine are as follows:

  • 0001A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose (Pfizer vaccine)
  • 0002A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose (Pfizer vaccine)
  • 0011A Immunization administration by intramuscular injection of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose (Moderna vaccine)
  • 0012A Immunization administration by intramuscular injection of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose (Moderna vaccine)

Note:

  • For vaccines that require multiple doses, communicate to patients to get both doses of the same vaccine
  • Evaluation and Management codes should not be billed in addition to the admin unless it is for a separately identifiable service
  • Bill for vaccine administration only

Will Capital BlueCross waive member cost share for the COVID-19 vaccine?

The vaccine itself will be paid for through funding authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act, but administration of the vaccine by a provider (network and non-network during the PHE) will be covered with no member cost share for both commercial and Medicare Advantage.